Table 12-2.
Analysis of AA detection rate in 3 cycles of screening, (%).
| 2012-2014 | 2015-2017 | 2018-2020 | ||
|---|---|---|---|---|
| AA | 5.10 | 7.44# | 7.67# | |
| Gender | ||||
| Male | 6.81 | 10.04# | 10.09# | |
| Female | 3.65 | 4.92# | 5.52# | |
| Age group | ||||
| 40-49 | 2.59# | 3.23# | 3.33# | |
| 50-59 | 3.85 | 6.87 | 5.68 | |
| 60-69 | 5.94 | 8.57# | 8.54# | |
| 70-74 | 7.95 | 11.58# | 12.67# | |
| Gender Distribution in Different Age Groups | ||||
| 40-49 | Male | 3.71# | 4.62# | 4.48# |
| Female | 1.66# | 1.85# | 2.03# | |
| 50-59 | Male | 5.59 | 9.82 | 7.76 |
| Female | 2.57 | 4.35# | 4.15# | |
| 60-69 | Male | 7.74 | 11.30# | 11.27# |
| Female | 4.35 | 5.81# | 5.98# | |
| 70-74 | Male | 9.02 | 13.87# | 14.27# |
| Female | 6.77# | 8.85#* | 10.86* | |
#/* No significant differences were observed between Screening methods; And statistically significant differences were detected between the other groups.